U.S. markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3200+0.0100 (+0.76%)
At close: 4:00PM EDT

1.3300 +0.01 (0.76%)
After hours: 6:59PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 10/17/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3-45.19%
S&P500 52-Week Change 314.38%
52 Week High 35.1900
52 Week Low 31.0000
50-Day Moving Average 31.6571
200-Day Moving Average 32.5207

Share Statistics

Avg Vol (3 month) 31.6M
Avg Vol (10 day) 31.43M
Shares Outstanding 583.62M
Float 55.43M
% Held by Insiders 117.82%
% Held by Institutions 166.40%
Shares Short (Sep 29, 2020) 42.22M
Short Ratio (Sep 29, 2020) 41.05
Short % of Float (Sep 29, 2020) 43.16%
Short % of Shares Outstanding (Sep 29, 2020) 42.62%
Shares Short (prior month Aug 30, 2020) 42.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Oct 23, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.87%
Return on Equity (ttm)-83.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-48.57M
EBITDA -54.83M
Net Income Avi to Common (ttm)-94.97M
Diluted EPS (ttm)-1.3090
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)107.88M
Total Cash Per Share (mrq)1.27
Total Debt (mrq)9.23M
Total Debt/Equity (mrq)7.63
Current Ratio (mrq)2.90
Book Value Per Share (mrq)1.43

Cash Flow Statement

Operating Cash Flow (ttm)-55.21M
Levered Free Cash Flow (ttm)-14.49M